Donovanosis epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Donovanosis}} | {{Donovanosis}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
{{CMG}} {{AE}} {{KD}} | {{CMG}} {{AE}} {{KD}} |
Revision as of 19:20, 4 December 2012
Donovanosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Donovanosis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Donovanosis epidemiology and demographics |
Risk calculators and risk factors for Donovanosis epidemiology and demographics |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]
Overview
Epidemiology and Demographics
Donovanosis is endemic in tropical and developing areas, including India, Guyana, New Guinea, central Australia, and southern Africa.
Age
Most infections occur in people ages 20-40. The disease is rarely seen in children or the elderly.
Gender
Men are affected more than twice as often as women.
References